Navigation Links
Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
Date:5/12/2010

usiness opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer
2. AEterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
3. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
4. AEterna Zentaris Announces Appointment of New Board Member
5. AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
6. AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
7. AEterna Zentaris Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma
8. AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer
9. AEterna Zentaris Receives US$5.5 Million from Institutional Investors
10. AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share
11. AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SANTA CLARA, Calif. , July 29, 2014 ... research services agreement with FORMA Therapeutics, Inc., to ... capabilities and proprietary fragment-based lead discovery platform for ... are really excited about the opportunity to work ... the fields of epigenetics and protein homeostasis. FORMA ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
(Date:7/29/2014)... July 29, 2014 Quorum Review ... has been awarded accreditation by the International ... its Lean Six Sigma Deployment Program. The citation ... improve performance. , Quorum’s Lean Six Sigma program ... Deployment Program designation. The designation is a public ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 The prestigious ... of Congress was recently awarded to Juliana Hillis and ... MA, for their project, “From an Egg, Everything: America’s ... 3,000 final entries for the National History Day program ... 300 historians and educators in Washington, D.C. , The ...
Breaking Biology Technology:Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 2In Vitro Fertilization (IVF) was the Subject of This Year’s Winning Entry for the Prestigious Library of Congress “Discovery or Exploration in History Award” 3
... Neptune Technologies ... in FUNCTIONAL FOOD market-- LAVAL, ... (NASDAQ.NEPT - TSX.V.NTB) reported today,that it entered a worldwide alliance ... Weider Global Nutrition for the distribution,of dietary supplements and functional ...
... 25 Osteotech, Inc.,(Nasdaq: OSTE ), a leader ... announced today the appointment of Cato T.,Laurencin, M.D., Ph.D. ... of Directors effective September 24, 2008 and will serve ... Board of Directors., Kenneth P. Fallon, III, Chairman ...
... 25 Vermillion, Inc.,(Nasdaq: VRML ), a ... notification from The NASDAQ Stock Market LLC that ... the Company,s,securities from The NASDAQ Capital Market, effective ... 25, 2008. The delisting is the result of,the ...
Cached Biology Technology:Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 2Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 3Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition 4Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2Vermillion Announces Receipt of NASDAQ Panel Decision 2Vermillion Announces Receipt of NASDAQ Panel Decision 3
(Date:7/29/2014)... genetics company, has received from the National Institutes ... a two-year project to support the further development ... genetic discovery. , Specifically, the grant supports ... web-based surveys to improve the company,s ability to ... survey tools to support the collection of a ...
(Date:7/29/2014)... There,s some good news for parents of preterm babies ... that by the time they become teenagers, the brains of ... born at term. , A study conducted by the University,s ... as the preterm child experiences no brain injury in early ... as good as their term-born peers. , However, the results ...
(Date:7/29/2014)... is a rare disease it affects 1 in 100,000 ... the esophageal wall. While its cause remains unknown, a new ... Belgium, the University of Bonn in Germany and other European ... in origin. The study, published on 6 July in ... mysterious disease. , When we swallow, a sphincter in the ...
Breaking Biology News(10 mins):23andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3Preterm children's brains can catch up years later 2Mysterious esophagus disease is autoimmune after all 2
... COLLEGE PARK, MD, April 7, 2009 -- Roughly 20 ... light homes, businesses, and other private and public spaces. ... it also presents a tremendous opportunity for savings. Improving ... a little -- could translate into dramatically lower energy ...
... the humble baker,s yeast has revealed surprising variation in ... as nature,s oldest clock. In a paper published in ... genes that are essential to all Earth,s organisms provide ... evolutionary journey. Ribosomal RNA sequence changes have been ...
... tiger salamanders used as live bait for freshwater fishing. ... largemouth bass, channel catfish and other freshwater fishes. ... for: salamanders in bait shops in Arizona, Colorado and ... Arizona, with a chytrid fungus called Batrachochytrium dendrobatidis (Bd). ...
Cached Biology News:Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 2Cheap and efficient white light LEDs new design described in AIP's Journal of Applied Physics 3Spring fishing season arrives... and with it, amphibian diseases 2Spring fishing season arrives... and with it, amphibian diseases 3
... Shakers combine high durability and performance ... The patented triple-counterbalanced heavy-duty mechanism ... run with heavy out-of-balance loads. ... contamination. The heavy stainless steel ...
... System features Saga GT , is an ... electrophoresis, lane finding, location of standards, calibration ... GT is second generation software developed ... developed at the University of Washington and ...
... BioPrime Plus Array CGH Genomic Labeling Systems ... reproducible labeling of genomic DNA samples for ... both indirect and direct labeling formats, the ... provide a flexible solution to your genomic ...
Request Info...
Biology Products: